164 related articles for article (PubMed ID: 6245710)
41. [The level of cyclic nucleotides and the activity of their phosphodiesterases in the peripheral blood lymphocytes in lung diseases during endolymphatic antibiotic therapy].
Feshchenko IuI; Spizhenko IuP
Ter Arkh; 1991; 63(8):7-10. PubMed ID: 1665248
[TBL] [Abstract][Full Text] [Related]
42. Characterization of cyclic-nucleotide phosphodiesterase activities in resting and N-formylmethionylleucylphenylalanine-stimulated human neutrophils.
Grady PG; Thomas LL
Biochim Biophys Acta; 1986 Mar; 885(3):282-93. PubMed ID: 3004603
[TBL] [Abstract][Full Text] [Related]
43. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
Kass DA
Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
[No Abstract] [Full Text] [Related]
44. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
Beatty CH; Herrington PT; Bocek RM
Biol Neonate; 1977; 32(1-2):33-42. PubMed ID: 198031
[TBL] [Abstract][Full Text] [Related]
45. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
Medvedeva MV
Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
[TBL] [Abstract][Full Text] [Related]
46. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
Nemecek GM; Butcher RW
J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
[TBL] [Abstract][Full Text] [Related]
47. Inhibition cyclic nucleotide phosphodiesterase by FPL 55712, an SRS-A antagonist.
Chasin M; Scott C
Biochem Pharmacol; 1978; 27(16):2065-7. PubMed ID: 214090
[No Abstract] [Full Text] [Related]
48. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
Nemoz G; Prigent AF
Ann Pharm Fr; 1984; 42(2):99-112. PubMed ID: 6091520
[No Abstract] [Full Text] [Related]
49. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
Nagasaka A; Hidaka H
Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233
[TBL] [Abstract][Full Text] [Related]
50. Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase.
Ho C; Teo TS; Desai R; Wang JH
Biochim Biophys Acta; 1976 Apr; 429(2):461-73. PubMed ID: 177071
[TBL] [Abstract][Full Text] [Related]
51. Cyclic guanosine 3',5'-monophosphate and phosphodiesterase activity in mitogen-stimulated human lymphocytes.
Takemoto DJ; Kaplan SA; Appleman MM
Biochem Biophys Res Commun; 1979 Sep; 90(2):491-7. PubMed ID: 41522
[No Abstract] [Full Text] [Related]
52. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
Sharma RV; Bhalla RC
Biochim Biophys Acta; 1978 Oct; 526(2):479-88. PubMed ID: 214127
[No Abstract] [Full Text] [Related]
53. 3',5' Cyclic nucleotide phosphodiesterase from human platelets: effect of heat upon the multiple forms and their interconversion.
Pichard AL; Choury D; Kaplan JC
Biochimie; 1981 Jul; 63(7):603-9. PubMed ID: 6269658
[TBL] [Abstract][Full Text] [Related]
54. Characterization of the soluble cyclic nucleotide phosphodiesterases in Xenopus laevis oocytes. Evidence for a calmodulin-dependent enzyme.
Miot F; Erneux C
Biochim Biophys Acta; 1982 Feb; 701(2):253-9. PubMed ID: 6280770
[TBL] [Abstract][Full Text] [Related]
55. Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets.
Matsuoka I; Suzuki T
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):341-53. PubMed ID: 6147364
[TBL] [Abstract][Full Text] [Related]
56. Activity of cyclic nucleotide phosphodiesterases in granulocytes of chronic myelogenous leukemia (CML). A preliminary report.
Naskalski JW; Uciński WS
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):134-40. PubMed ID: 2581858
[TBL] [Abstract][Full Text] [Related]
57. S-100 antigen and calmodulin in human leukemic cells.
Wada H; Shirakawa S; Yamakado T; Ohkubo S; Tanaka T; Yamamoto T; Hidaka H
Leuk Res; 1989; 13(1):65-9. PubMed ID: 2536871
[TBL] [Abstract][Full Text] [Related]
58. Regulation of cyclic nucleotide phosphodiesterase activity in human lung fibroblasts.
Duttagupta C; Rifas L; Makman MH
Biochim Biophys Acta; 1978 Apr; 523(2):385-94. PubMed ID: 207333
[TBL] [Abstract][Full Text] [Related]
59. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
60. Phosphatidylethanolamine methyltransferase and cAMP, cGMP phosphodiesterases in lymphocytes and monocytes in sarcoidosis.
Pacheco Y; Dubois M; Prigent AF; Fonlupt P; Timouyasse L; Rey C; Chambe MT; Biot N; Perrin-Fayolle M; Pacheco H
Clin Chim Acta; 1987 Mar; 163(3):267-77. PubMed ID: 3034451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
